The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Open accessAbstract
Psychedelics produce fast and persistent antidepressant effects and induce neuroplasticity resembling the effects of clinically approved antidepressants. We recently reported that pharmacologically diverse antidepressants, including fluoxetine and ketamine, act by binding to TrkB, the receptor for BDNF. Here we show that lysergic acid diethylamide (LSD) and psilocin directly bind to TrkB with affinities 1,000-fold higher than those for other antidepressants, and that psychedelics and antidepressants bind to distinct but partially overlapping sites within the transmembrane domain of TrkB dimers. The effects of psychedelics on neurotrophic signaling, plasticity and antidepressant-like behavior in mice depend on TrkB binding and promotion of endogenous BDNF signaling but are independent of serotonin 2A receptor (5-HT 2A ) activation, whereas LSD-induced head twitching is dependent on 5-HT 2A and independent of TrkB binding. Our data confirm TrkB as a common primary target for antidepressants and suggest that high-affinity TrkB positive allosteric modulators lacking 5-HT 2A activity may retain the antidepressant potential of psychedelics without hallucinogenic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“it is possible that the psychedelic experience is necessary to produce the therapeutic benefits”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [110]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another study reports that the combination of lysergic acid diethylamide (LSD) and psilocybin may exert long-term antidepressant effects by promoting neural plasticity, which dose not involve in the hallucinogenic effects. 384”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [384]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across disease models, TrkB-positive allosteric modulators (PAMs) rescue spine density and preserve mature spine morphology, supporting a model in which TrkB modulation extends antidepressant like plasticity through sustained structural and proteomic reinforcement [33,116,118].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [116]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“According to rodent research, psychedelics may promote synaptic connections by enhancing BDNF-TrkB signaling similar to typical antidepressants [138].”
From Beyond the serotonin deficit hypothesis: Communicating a neuroplasticity framework of major depressive disorder (2024) · cites this paper as [138]
The cited source says what the claim attributes to it.
In the citing paper
“It has recently been demonstrated that conventional antidepressants such as fluoxetine and imipramine, as well as the rapid-acting glutamatergic agent ketamine, directly bind to TrkB and allosterically potentiate BDNF signaling [52,54].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [54]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952
Comparison of simple potential functions for simulating liquid water
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983) · The Journal of Chemical Physics · doi:10.1063/1.445869 · Cited by 41,298
Matplotlib: a 2D graphics environment
Hunter, J. D. (2007) · Computing in Science & Engineering · doi:10.1109/mcse.2007.55 · Cited by 39,249
SciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2020) · Nature Methods · doi:10.1038/s41592-019-0686-2 · Cited by 38,430
Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015) · SoftwareX · doi:10.1016/j.softx.2015.06.001 · Cited by 27,190
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
SciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2019) · Apollo - University of Cambridge Repository · doi:10.17863/cam.64134 · Cited by 10,460
LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
Laskowski, R. A., & Swindells, M. B. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200227u · Cited by 6,471
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr101065j · Cited by 5,500
Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid Types
Klauda, J. B., Venable, R. M., Freites, J. A., O’Connor, J. W., Tobias, D. J., Mondragon-Ramirez, C., Vorobyov, I., MacKerell, A. D., & Pastor, R. W. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp101759q · Cited by 4,501
Research works printed but not linked: 1
- PubChem. PubChem https://pubchem.ncbi.nlm.nih.gov/ (2023).
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“384 Psilocybin, a classical psychedelic, can play its antidepressant roles by activating 5-HT 2A receptors (5-HT 2A R).”
BackgroundTargeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 190
Correia, A. S., Cardoso, A., & Vale, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082081 · Cited by 154
The neuroplastic brain: current breakthroughs and emerging frontiers
Gazerani, P. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149643 · Cited by 174
“Psychedelics such as psilocybin, ketamine, and LSD have demonstrated rapid and sustained effects on synaptic remodeling.”
Beyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action
Cameron, L. P., Benetatos, J., Lewis, V., Bonniwell, E. M., Jaster, A. M., Moliner, R., Ċastrén, E., McCorvy, J. D., Palner, M., & Aguilar‐Valles, A. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1384-23.2023 · Cited by 109
Self-citation
Metadata
- Authors
- Moliner, R., Girych, M., Brunello, C. A., Kovaleva, V., Biojone, C., Enkavi, G., Antenucci, L., Kot, E. F., Goncharuk, S. A., Kaurinkoski, K., Kuutti, M., Fred, S. M., Elsilä, L. V., Sakson, S., Cannarozzo, C., Diniz, C. R. A. F., Seiffert, N., Rubiolo, A., Haapaniemi, H., Meshi, E., Nagaeva, E., Öhman, T., Róg, T., Kankuri, E., Vilar, M., Varjosalo, M., Korpi, E. R., Permi, P., Mineev, K. S., Saarma, M., Vattulainen, I., Casarotto, P. C., & Castrén, E.
- Affiliations
- University of Helsinki (FI)
- University of Jyväskylä (FI)
- Moscow Institute of Physics and Technology (RU)
- Universidade de São Paulo (BR)
- University of Trieste (IT)
- Instituto de Biomedicina de Valencia (ES)
- Goethe University Frankfurt (DE)
- Corresponding author
- Vattulainen, Ilpo
- Casarotto, Plinio C.
- ORCID
- Moliner, Rafael
- Girych, Mykhailo
- Brunello, Cecilia A.
- Kovaleva, Vera
- Biojone, Caroline
- Enkavi, Giray
- Antenucci, Lina
- Kot, Erik F.
- Goncharuk, Sergey A.
- Kaurinkoski, Katja
- Kuutti, Mirjami
- Fred, Senem M.
- Elsilä, Lauri V.
- Sakson, Sven
- Cannarozzo, Cecilia
- Diniz, Cassiano R. A. F.
- Seiffert, Nina
- Rubiolo, Anna
- Haapaniemi, Hele
- Meshi, Elsa
- Nagaeva, Elina
- Öhman, Tiina
- Róg, Tomasz
- Kankuri, Esko
- Vilar, Marçal
- Varjosalo, Markku
- Korpi, Esa R.
- Permi, Perttu
- Mineev, Konstantin S.
- Saarma, Mart
- Vattulainen, Ilpo
- Casarotto, Plinio C.
- Castrén, Eero
- Venue
- Nature Neuroscience
- Published
- 2023-06
- Volume
- 26
- Issue
- 6
- Pages
- 1032-1041
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC10244169
- OpenAlex
- W4379469019
- Cited by
- 478
- References
- 91
- Citations by year
- 2026: 141 · 2025: 157 · 2024: 127 · 2023: 53
- FWCI
- 139.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 4 d)
- Locations
- Nature Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Jyväskylä University Digital Archive (University of Jyväskylä) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- Academy of Finland (294710, 303124, 307416, 327192)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- psychedelics, TrkB receptor, brain-derived neurotrophic factor, neuroplasticity, antidepressant effects, LSD, psilocin, 5-HT2A receptor, neurotrophic signaling, positive allosteric modulators, fluoxetine, ketamine
- MeSH terms
- Allosteric Regulation, Animals, Antidepressive Agents, Binding Sites, Embryo, Mammalian, Female, Hallucinogens, Humans, Lysergic Acid Diethylamide, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Neuronal Plasticity, Neurons, Psilocybin, Signal Transduction, Brain-Derived Neurotrophic Factor, Receptor, trkB, Mice, Molecular Dynamics Simulation, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. https://app.cochat.ai/papers/10.1038/s41593-023-01316-5
- The paper
- Moliner, R., Girych, M., Brunello, C. A., Kovaleva, V., Biojone, C., Enkavi, G., Antenucci, L., Kot, E. F., Goncharuk, S. A., Kaurinkoski, K., Kuutti, M., Fred, S. M., Elsilä, L. V., Sakson, S., Cannarozzo, C., Diniz, C. R. A. F., Seiffert, N., Rubiolo, A., Haapaniemi, H., . . . Castrén, E. (2023). Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nature Neuroscience. https://doi.org/10.1038/s41593-023-01316-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.